Nanoscale , 2015, 7,1392-1402
DOI: 10.1039/C4NR03875D, Paper
DOI: 10.1039/C4NR03875D, Paper
Manakamana Khanal, Alexandre Barras, Thibaut Vausselin, Lucie Feneant, Rabah Boukherroub, Aloysius Siriwardena, Jean Dubuisson, Sabine Szunerits
Boronic acid-modified lipid nanocapsules are shown to be efficient inhibitors of hepatitis C virus (HCV) entry.
The content of this RSS Feed (c) The Royal Society of Chemistry
Boronic acid-modified lipid nanocapsules are shown to be efficient inhibitors of hepatitis C virus (HCV) entry.
The content of this RSS Feed (c) The Royal Society of Chemistry
Click for full article
No comments:
Post a Comment